Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CCTV+: Peng Liyuan addresses World Tuberculosis Day video conference 2022-03-25 11:04
Harbour BioMed Reports Full Year 2021 Financial Results: Empower Value Creation with Global Innovation Capabilities 2022-03-25 10:22
CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2021 ANNUAL RESULTS (H SHARES) 2022-03-24 22:39
New clinical trial collaboration for Cu-64 SAR-bisPSMA in prostate cancer 2022-03-24 21:08
Orion Health to deliver the world's largest health information exchange in Saudi Arabia 2022-03-24 02:00
CARsgen 2021 Annual Results: Steady Advancement in Innovative CAR T Products and Technologies 2022-03-23 20:50
CARsgen Announces First Patient Enrollment in the Confirmatory Phase II Clinical Trial of CT041 in China 2022-03-23 20:50
Smartee Raises US$ 80 Million in Series D Funding 2022-03-23 20:40
Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results 2022-03-23 15:40
InnoCare Releases 2021 Annual Results and Business Highlights 2022-03-23 08:08
VivaVision Biotech Announces Positive Topline Results of VVN001 in the Phase 2 Clinical Study for the Treatment of Dry Eye Disease 2022-03-23 08:00
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively 2022-03-23 06:53
WuXi Biologics Achieved Record Growth and Profitability in 2021 2022-03-23 00:38
INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use 2022-03-23 00:00
Jacobio Announces Annual Results of 2021, R&D Investment Increases 83% 2022-03-22 22:50
IFF to Showcase Renewable Industrial Solutions and Polymer Portfolio at American Coatings Show 2022-03-22 21:00
NIBIOHN Identifies Tissue-specific Exosome Marker Candidates from Blood 2022-03-22 14:00
OBiO Technology Goes Public on Shanghai Stock Exchange Today 2022-03-22 13:00
INTERVAPOR®, THERMAL VAPOR TREATMENT SYSTEM, APPROVED FOR MARKETING IN CHINA 2022-03-22 10:34
Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation by the US FDA for the Treatment of Neuroblastoma 2022-03-22 09:15
1 167 168 169 170 171 812